advertisement

---

Azuara-Blanco A 9

Showing records 1 to 9 | Display all abstracts from Azuara-Blanco A

104741 Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma
Kernohan A
British Journal of Ophthalmology 2022; 0:

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Clement Freiberg J
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104741 Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma
Homer T
British Journal of Ophthalmology 2022; 0:

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
von Spreckelsen A
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104741 Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma
Shabaninejad H
British Journal of Ophthalmology 2022; 0:

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Kolko M; Azuara-Blanco A
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104741 Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma
King AJ; Hudson J
British Journal of Ophthalmology 2022; 0:

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Virgili G
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104741 Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma
Fernie G; Azuara-Blanco A; Burr J; Sparrow JM; Garway-Heath D; Barton K; Norrie J; Maclennan G; Vale L
British Journal of Ophthalmology 2022; 0:

---